Brain atrophy and clinical characteristics predicting SDMT performance in multiple sclerosis: A 10-year follow-up study.
Cecilie JacobsenRobert ZivadinovKjell-Morten MyhrTuri O DalakerIngvild DalenRalph Hb BenedictNiels P BergslandElisabeth FarbuPublished in: Multiple sclerosis journal - experimental, translational and clinical (2021)
This longitudinal study shows that baseline MRI-markers, demographic and clinical data can help predict worsening IPS. Identification of patients at risk of IPS decline is of importance as follow-up, treatment and rehabilitation can be optimized.